Drug Profile
KAL-HI
Latest Information Update: 28 Jul 1998
Price :
$50
*
At a glance
- Originator Nihon Iyakuhin Kogyo
- Class Infertility therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Male infertility
Most Recent Events
- 28 Jul 1998 Discontinued-II for Male infertility in Japan (PO)
- 04 Jun 1997 Discontinued-II for Infertility in Japan (PO)